Crystal structure of 6-[(3,5-dimethylphenyl)thio]-5-ethylpyrimidine-2,4(1 H ,3 H )-dione, C ₁₄ H ₁₆ N ₂ O ₂ S

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Crystal structure of 3-(3,5-bis(trifluoromethyl)benzyl)-2-methyl-6-phenylpyrimidin-4(3 <i>H</i> )-one, C ₂₀ H ₁₄ F ₆ N ₂ OOriginal Research · 2026
2. 2The crystal structure of 4-(4-phenyl-5-(((1-(2,4,6-tribromophenyl)-1<i>H</i>-1,2,3-triazol-4-yl)methyl)thio)-4<i>H</i>-1,2,4-triazol-3-yl)pyridine, C₂₂H₁₄Br₃N₇S2024
3. 3Crystal structure of 6,6′-((1<i>E</i>,1′<i>E</i>)-((2-phenylpyrimidine-4,6-diyl)bis(hydrazin-2-yl-1-ylidene))bis(methaneylylidene))bis(2-methoxyphenol)monohydrate, C₂₆H₂₆N₆O₅2024
4. 4Crystal structure of 3-(diethylamino)-7-ethyl-2′-((pyridin-3-ylmethylene)amino)-7 <i>H</i> -spiro[chromeno[2,3- <i>b</i> ]phenothiazine-14,1′-isoindolin]-3′-one-methanol, C ₃₈ H ₃₃ N ₅ O ₂ SOriginal Research · 2026
5. 5The twinned crystal structure of 4-chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7 <i>H</i> -pyrrolo[2,3- <i>d</i> ]pyrimidine, C ₁₂ H ₁₈ ClN ₃ OSiOriginal Research · 2026